LIV-1/Zip6 Antibody (ladiratuzumAb) [DyLight 550]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-28849R
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Flow Cytometry, Functional
Label
DyLight 550 (Excitation = 562 nm, Emission = 576 nm)
Antibody Source
Recombinant Monoclonal Human IgG1 Clone # ladiratuzumAb
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
LIV-1 / SLC39A6
Clonality
Monoclonal
Host
Human
Isotype
IgG1
Applications for LIV-1/Zip6 Antibody (ladiratuzumAb) [DyLight 550]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Functional
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: LIV-1/Zip6
Alternate Names
LIV-1, solute carrier family 39 (zinc transporter), member 6, zinc transporter ZIP6
Gene Symbol
SLC39A6
Additional LIV-1/Zip6 Products
Product Documents for LIV-1/Zip6 Antibody (ladiratuzumAb) [DyLight 550]
Product Specific Notices for LIV-1/Zip6 Antibody (ladiratuzumAb) [DyLight 550]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...